Evidence map›Paper›PMID 35079047›Full record

ArticleScientific reports2022

Aptamer based point of care diagnostic for the detection of food allergens.

Sarah Stidham, Valerie Villareal, Vasant Chellappa, Lucas Yoder, Olivia Alley, Wayne Shreffler, Jonathan Spergel, David Fleischer, Hugh Sampson, Adi Gilboa-Geffen

Abstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Sarah StidhamDOTS Technology Corp, Natick, USA.
Valerie VillarealDOTS Technology Corp, Natick, USA.
Vasant ChellappaDOTS Technology Corp, Natick, USA.
Lucas YoderDOTS Technology Corp, Natick, USA.
Olivia AlleyDOTS Technology Corp, Natick, USA.
Wayne ShrefflerMassachusetts General Hospital, Boston, USA.
Jonathan SpergelChildren's Hospital of Philadelphia, Philadelphia, USA.
David FleischerChildren's Hospital Colorado, Aurora, USA.
Hugh SampsonMount Sinai, New York, USA.
Adi Gilboa-GeffenDOTS Technology Corp, Natick, USA. agilboa@dotscorp.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aptamers, due to their small size, strong target affinity, and ease of chemical modification, are ideally suited for molecular detection technologies. Here, we describe successful use of aptamer technology in a consumer device for the detection of peanut antigen in food. The novel aptamer-based protein detection method is robust across a wide variety of food matrices and sensitive to peanut protein at concentrations as low as 12.5 ppm (37.5 µg peanut protein in the sample). Integration of the assay into a sensitive, stable, and consumer friendly portable device will empower users to easily and quickly assess the presence of peanut allergens in foods before eating. With many food reactions occurring outside the home, the type of technology described here has significant potential to improve lives for children and families.

Indexed as

Point-of-Care TestingAllergensAntigens, PlantAptamers, NucleotideArachisFood AnalysisFood HypersensitivityHumansMembrane ProteinsPlant ProteinsProtein BindingSensitivity and SpecificityAllergensAntigens, PlantAptamers, NucleotideAra h 1 protein, Arachis hypogaeaMembrane ProteinsPlant Proteins

Identifiers

PMID35079047
PMCPMC8789827

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.